NOVARTIS ERFIND VERWALT GMBH has a total of 28 patent applications. Its first patent ever was published in 1988. It filed its patents most often in Austria, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are NORVATIS AG, ALKERMES INC and ALBIREO AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Austria | 19 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Republic of Korea | 2 | |
#4 | Taiwan | 2 | |
#5 | Australia | 1 | |
#6 | Mexico | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Macromolecular chemistry and polymers | |
#5 | Optics | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Sugars | |
#6 | Optical systems | |
#7 | Unspecified technologies | |
#8 | Special macromolecular compounds | |
#9 | Polysaccharides | |
#10 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Chabrecek Peter | 2 |
#2 | Bachmann Frank | 2 |
#3 | Lohmann Dieter | 2 |
#4 | Ramage Paul Dr | 1 |
#5 | Rapold Thomas | 1 |
#6 | Pless Janos | 1 |
#7 | Burkhardt Stephan | 1 |
#8 | Gram Hermann Dr | 1 |
#9 | Waelchli Rudolf Dr | 1 |
#10 | Hall Jonathan | 1 |
Publication | Filing date | Title |
---|---|---|
ATA12282000A | Pharmaceutical formulations | |
ATA31798A | Pharmaceutical composition containing ciclosporin | |
ATA172297A | Pharmaceutical preparations contg macrolide antibiotics - contain, as the carrier, a mixt of a hydrophilic phase, a lipophilic phase and a surfactant | |
KR19990014908A | Process for the Catalytic Hydrogenation of Aromatic Nitro Compounds | |
TW291481B | Poly-unsaturated carbohydrate derivatives, polymers thereof and their use | |
TW307775B | Unsaturated carbohydrate derivatives, polymers thereof and their use | |
ATA79491A | New sugar derivs. of biologically active peptide(s) - have prolonged duration of action, and are coupled by other than direct N-glycoside bond or direct amide bond | |
ATA273988A | Novel use of 11,28-dioxa-4- azatricyclo(22.3.1.04,9)octacos-18-ene derivatives and pharmaceutical preparations containing them | |
ATA259288A | Process for the production of a liquid pharmaceutical composition for nasal administration of a calcitonin as nasal spray |